SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

J.B. Chemicals & Pharmaceuticals informs about disclosure

29 Aug 2024 Evaluate
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), J.B. Chemicals & Pharmaceuticals has informed that the Company has received Order from Deputy Commissioner of State Tax, Bihar. The relevant information in the format prescribed by SEBI vide its circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed.

The above information is a part of company’s filings submitted to BSE.

JB Chem & Pharma Share Price

2457.60 19.95 (0.82%)
13-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.05
Dr. Reddys Labs. 1234.60
Cipla 1426.80
Zydus Lifesciences 1131.05
Lupin 2497.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: